Home Tags Has announced it has completed a financing round which raised US$23 million (A$34 million) in new funds.
Tag: has announced it has completed a financing round which raised US$23 million (A$34 million) in new funds.
Vaxxas raises $34 million to clinically advance needle-free vaccines, including a next-generation COVID-19 vaccine...
Vaxxas, a clinical-stage biotechnology company commercializing a novel vaccination platform, has announced it has completed a financing round which raised US$23 million (A$34 million) in new funds.
Featured Article
How a small pet food manufacturer supports a 5x increase in production capacity
For Advanced Pet Care of Australia, scaling into one of Australia’s top pet food manufacturers required more than new production capacity – it required better systems.
